Anaphylaxis
Anaphylaxis is a potentially life-threatening allergic reaction - look for life-threatening problems:[21]Resuscitation Council UK. Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. 2021 [internet publication].
https://www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis/emergency-treatment
[22]Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-23.
https://www.jacionline.org/article/S0091-6749(20)30105-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32001253?tool=bestpractice.com
[23]Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024 Feb;132(2):124-76.
https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/38108678?tool=bestpractice.com
[24]Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council guidelines 2021: cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.
https://www.resuscitationjournal.com/article/S0300-9572(21)00064-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33773826?tool=bestpractice.com
If anaphylaxis is present:[21]Resuscitation Council UK. Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. 2021 [internet publication].
https://www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis/emergency-treatment
[22]Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-23.
https://www.jacionline.org/article/S0091-6749(20)30105-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32001253?tool=bestpractice.com
[24]Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council guidelines 2021: cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.
https://www.resuscitationjournal.com/article/S0300-9572(21)00064-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33773826?tool=bestpractice.com
Call for help
Remove trigger if possible (e.g., stop any infusion)
Lie patient flat
Give intramuscular adrenaline
Establish airway
Give high flow oxygen
Apply monitoring: pulse oximetry, ECG, blood pressure
Repeat intramuscular adrenaline after 5 mins
Give intravenous fluid bolus
The comprehensive management of anaphylactic shock is beyond the scope of this topic and guidelines should be consulted for more detail.[21]Resuscitation Council UK. Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. 2021 [internet publication].
https://www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis/emergency-treatment
[22]Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-23.
https://www.jacionline.org/article/S0091-6749(20)30105-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32001253?tool=bestpractice.com
[23]Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024 Feb;132(2):124-76.
https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/38108678?tool=bestpractice.com
[25]Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020 Oct;13(10):100472.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607509
http://www.ncbi.nlm.nih.gov/pubmed/33204386?tool=bestpractice.com
Angio-oedema with airway compromise
Episodes of urticaria with angio-oedema affecting the head and neck, which could potentially compromise the airway, should be treated promptly with adrenaline (epinephrine). Stridor, odynophagia, dysphagia, or respiratory distress may be signs of laryngeal oedema, which can lead to respiratory arrest. The status of the airway should be assessed and closely monitored in all patients with angio-oedema, and all necessary steps must be taken to ensure the airway is always secured. In severe cases, consultation with an airway management specialist, for example an anaesthetist or otolaryngologist may be necessary. Airway compromise in patients with hereditary angio-oedema is beyond the scope of this topic and guidelines should be consulted for more detail.[26]Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021 Jan;9(1):132-50.
https://www.jaci-inpractice.org/article/S2213-2198(20)30878-3/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32898710?tool=bestpractice.com
Angio-oedema in the absence of urticaria
Angio-oedema that occurs in the absence of urticaria, especially when involving airway compromise, mandates consideration for serious conditions, such as:
Hereditary angio-oedema (HAE; due to inhibition of the complement/kinin metabolism):
Typically lasts for a few days
Often described as painful.[27]Betschel S, Badiou J, Binkley K, et al. The International/Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol. 2019;15:72.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878678
http://www.ncbi.nlm.nih.gov/pubmed/31788005?tool=bestpractice.com
Acquired angio-oedema (with C1 inhibitor consumption from secondary causes, such as malignancy/autoimmune disease):
Angio-oedema with normal C1 inhibitor:
May be drug-induced, e.g., due to angiotensin-converting-enzyme inhibitors. Often starts within weeks of starting the drug, but a significant number of patients are asymptomatic for years before the onset of swelling.
Recognition is paramount, as these patients are unlikely to respond to adrenaline (epinephrine) and require C1 inhibitor replacement or bradykinin-blocking agents.[3]European Dermatology Forum. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Sep 2021 [internet publication].
https://www.guidelines.edf.one//uploads/attachments/cl263w4y200oilajn3li6nqa1-urticaria-2021-gl.pdf
[4]Sabroe RA, Lawlor F, Grattan CEH, et al. British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021. Br J Dermatol. 2022 Mar;186(3):398-413.
https://academic.oup.com/bjd/article/186/3/398/6705777
http://www.ncbi.nlm.nih.gov/pubmed/34773650?tool=bestpractice.com
[27]Betschel S, Badiou J, Binkley K, et al. The International/Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol. 2019;15:72.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878678
http://www.ncbi.nlm.nih.gov/pubmed/31788005?tool=bestpractice.com
Patients with HAE should, at a minimum, have access to emergency rescue medication (dependent on local availability) in the event of attacks. Generally, these patients should be managed by clinicians who are experienced with managing HAE. Airway compromise in patients with hereditary angio-oedema is beyond the scope of this topic and guidelines should be consulted for more detail.[26]Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021 Jan;9(1):132-50.
https://www.jaci-inpractice.org/article/S2213-2198(20)30878-3/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32898710?tool=bestpractice.com